Harrow Health Stock Price To Earning

HROW Stock

USD 38.08 1.94 4.85%

Harrow Health fundamentals help investors to digest information that contributes to Harrow Health's financial success or failures. It also enables traders to predict the movement of Harrow Stock. The fundamental analysis module provides a way to measure Harrow Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Harrow Health stock.

Total Liab Other Stockholder Equity

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Harrow Health Company Price To Earning Analysis

Harrow Health's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.

P/E

Market Value Per Share

Earnings Per Share

More About Price To Earning | All Equity Analysis

Current Harrow Health Price To Earning

24.45 X

Most of Harrow Health's fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Harrow Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Harrow Price To Earning Driver Correlations

Understanding the fundamental principles of building solid financial models for Harrow Health is extremely important. It helps to project a fair market value of Harrow Stock properly, considering its historical fundamentals such as Price To Earning. Since Harrow Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Harrow Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Harrow Health's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Total Liab	Total Current Assets	Common Stock	Accounts Payable	Long Term Debt	Net Tangible Assets	Current Deferred Revenue	Capital Surpluse	Short Term Debt	Property Plant Equipment	Short Term Investments	Net Receivables	Good Will	Long Term Debt Total	Intangible Assets	Deferred Long Term Liab	Short Long Term Debt	Net Invested Capital	Long Term Investments	Net Working Capital	Capital Stock
Total Assets		0.94	0.95	-0.82	1.0	0.97	0.58	0.95	0.99	-0.13	0.27	0.65	-0.11	0.26	0.23	0.96	-0.3	0.95	0.96	0.5	0.58	1.0	-0.49	0.8	0.95
Total Stockholder Equity	0.94		0.9	-0.75	0.91	0.9	0.56	0.88	0.88	0.19	0.25	0.63	0.03	0.28	0.43	0.93	-0.34	0.81	0.91	0.51	0.54	0.93	-0.48	0.7	0.87
Net Debt	0.95	0.9		-0.76	0.94	0.85	0.52	0.84	0.92	-0.17	0.22	0.55	-0.05	0.29	0.24	0.97	-0.22	0.84	0.96	0.46	0.5	0.94	-0.37	0.63	0.86
Retained Earnings	-0.82	-0.75	-0.76		-0.82	-0.84	-0.83	-0.85	-0.8	0.07	-0.3	-0.91	-0.1	-0.67	-0.38	-0.72	-0.07	-0.83	-0.69	-0.67	-0.74	-0.78	0.25	-0.77	-0.79
Total Liab	1.0	0.91	0.94	-0.82		0.97	0.58	0.95	1.0	-0.21	0.28	0.65	-0.15	0.25	0.17	0.96	-0.28	0.97	0.95	0.49	0.58	1.0	-0.48	0.82	0.95
Total Current Assets	0.97	0.9	0.85	-0.84	0.97		0.66	0.97	0.97	-0.08	0.32	0.73	-0.09	0.27	0.28	0.87	-0.35	0.97	0.86	0.56	0.66	0.96	-0.47	0.91	0.95
Common Stock	0.58	0.56	0.52	-0.83	0.58	0.66		0.64	0.56	0.15	0.4	0.93	0.33	0.66	0.58	0.44	-0.03	0.63	0.4	0.82	0.81	0.55	-0.03	0.76	0.67
Accounts Payable	0.95	0.88	0.84	-0.85	0.95	0.97	0.64		0.95	-0.11	0.43	0.73	-0.08	0.36	0.25	0.87	-0.2	0.94	0.86	0.54	0.6	0.95	-0.55	0.87	0.92
Long Term Debt	0.99	0.88	0.92	-0.8	1.0	0.97	0.56	0.95		-0.26	0.25	0.63	-0.2	0.21	0.12	0.94	-0.3	0.98	0.94	0.47	0.56	0.99	-0.48	0.82	0.94
Net Tangible Assets	-0.13	0.19	-0.17	0.07	-0.21	-0.08	0.15	-0.11	-0.26		-0.01	0.13	0.5	0.17	0.74	-0.17	-0.19	-0.29	-0.2	0.24	0.1	-0.17	0.12	-0.09	-0.13
Current Deferred Revenue	0.27	0.25	0.22	-0.3	0.28	0.32	0.4	0.43	0.25	-0.01		0.34	0.52	0.47	0.32	0.21	0.28	0.28	0.19	0.21	0.46	0.27	-0.36	0.38	0.27
Capital Surpluse	0.65	0.63	0.55	-0.91	0.65	0.73	0.93	0.73	0.63	0.13	0.34		0.23	0.68	0.52	0.51	0.03	0.69	0.47	0.81	0.82	0.61	-0.14	0.81	0.73
Short Term Debt	-0.11	0.03	-0.05	-0.1	-0.15	-0.09	0.33	-0.08	-0.2	0.5	0.52	0.23		0.59	0.63	-0.12	0.22	-0.2	-0.18	0.1	0.51	-0.15	0.11	-0.07	-0.12
Property Plant Equipment	0.26	0.28	0.29	-0.67	0.25	0.27	0.66	0.36	0.21	0.17	0.47	0.68	0.59		0.5	0.21	0.57	0.23	0.15	0.45	0.58	0.2	0.05	0.24	0.2
Short Term Investments	0.23	0.43	0.24	-0.38	0.17	0.28	0.58	0.25	0.12	0.74	0.32	0.52	0.63	0.5		0.14	-0.12	0.13	0.09	0.64	0.5	0.19	0.22	0.29	0.23
Net Receivables	0.96	0.93	0.97	-0.72	0.96	0.87	0.44	0.87	0.94	-0.17	0.21	0.51	-0.12	0.21	0.14		-0.25	0.85	1.0	0.36	0.45	0.97	-0.53	0.64	0.88
Good Will	-0.3	-0.34	-0.22	-0.07	-0.28	-0.35	-0.03	-0.2	-0.3	-0.19	0.28	0.03	0.22	0.57	-0.12	-0.25		-0.3	-0.27	-0.13	-0.08	-0.34	0.06	-0.36	-0.39
Long Term Debt Total	0.95	0.81	0.84	-0.83	0.97	0.97	0.63	0.94	0.98	-0.29	0.28	0.69	-0.2	0.23	0.13	0.85	-0.3		0.85	0.53	0.63	0.95	-0.41	0.9	0.93
Intangible Assets	0.96	0.91	0.96	-0.69	0.95	0.86	0.4	0.86	0.94	-0.2	0.19	0.47	-0.18	0.15	0.09	1.0	-0.27	0.85		0.34	0.41	0.96	-0.55	0.63	0.87
Deferred Long Term Liab	0.5	0.51	0.46	-0.67	0.49	0.56	0.82	0.54	0.47	0.24	0.21	0.81	0.1	0.45	0.64	0.36	-0.13	0.53	0.34		0.53	0.47	0.05	0.69	0.6
Short Long Term Debt	0.58	0.54	0.5	-0.74	0.58	0.66	0.81	0.6	0.56	0.1	0.46	0.82	0.51	0.58	0.5	0.45	-0.08	0.63	0.41	0.53		0.55	-0.06	0.74	0.64
Net Invested Capital	1.0	0.93	0.94	-0.78	1.0	0.96	0.55	0.95	0.99	-0.17	0.27	0.61	-0.15	0.2	0.19	0.97	-0.34	0.95	0.96	0.47	0.55		-0.51	0.8	0.95
Long Term Investments	-0.49	-0.48	-0.37	0.25	-0.48	-0.47	-0.03	-0.55	-0.48	0.12	-0.36	-0.14	0.11	0.05	0.22	-0.53	0.06	-0.41	-0.55	0.05	-0.06	-0.51		-0.34	-0.47
Net Working Capital	0.8	0.7	0.63	-0.77	0.82	0.91	0.76	0.87	0.82	-0.09	0.38	0.81	-0.07	0.24	0.29	0.64	-0.36	0.9	0.63	0.69	0.74	0.8	-0.34		0.91
Capital Stock	0.95	0.87	0.86	-0.79	0.95	0.95	0.67	0.92	0.94	-0.13	0.27	0.73	-0.12	0.2	0.23	0.88	-0.39	0.93	0.87	0.6	0.64	0.95	-0.47	0.91

Click cells to compare fundamentals

Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.

Competition

Predict Harrow Health

Harrow Retained Earnings

Retained Earnings

(127.21 Million)

Harrow Health reported Retained Earnings of (133.9 Million) in 2023

Based on the latest financial disclosure, Harrow Health has a Price To Earning of 24.45 times. This is 5.38% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The price to earning for all United States stocks is 14.87% higher than that of the company.

Harrow Price To Earning Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Harrow Health's direct or indirect competition against its Price To Earning to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Harrow Health could also be used in its relative valuation, which is a method of valuing Harrow Health by comparing valuation metrics of similar companies.

Harrow Health is currently under evaluation in price to earning category among its peers.

Harrow Health Current Valuation Drivers

We derive many important indicators used in calculating different scores of Harrow Health from analyzing Harrow Health's financial statements. These drivers represent accounts that assess Harrow Health's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Harrow Health's important valuation drivers and their relationship over time.

	2019	2020	2021	2022	2023	2024 (projected)
Market Cap	197.0M	177.6M	231.2M	405.3M	365.3M	383.6M
Enterprise Value	213.3M	197.1M	267.0M	413.2M	481.7M	505.8M

Harrow Health ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Harrow Health's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Harrow Health's managers, analysts, and investors.

Environmental

Governance

Social

Harrow Fundamentals

	Return On Equity	-0.5
	Return On Asset	-0.0168
	Profit Margin	(0.20) %
	Operating Margin	0.03 %
	Current Valuation	1.61 B
	Shares Outstanding	35.61 M
	Shares Owned By Insiders	14.11 %
	Shares Owned By Institutions	59.17 %
	Number Of Shares Shorted	2.51 M
	Price To Earning	24.45 X
	Price To Book	25.71 X
	Price To Sales	8.43 X
	Revenue	130.19 M
	Gross Profit	63.21 M
	EBITDA	9.72 M
	Net Income	(24.41 M)
	Cash And Equivalents	51.7 M
	Cash Per Share	1.91 X
	Total Debt	190.5 M
	Current Ratio	5.01 X
	Book Value Per Share	1.64 X
	Cash Flow From Operations	3.84 M
	Short Ratio	3.76 X
	Earnings Per Share	(0.95) X
	Price To Earnings To Growth	(2.50) X
	Target Price	60.85
	Number Of Employees	315
	Beta	0.76
	Market Capitalization	1.43 B
	Total Asset	312.16 M
	Retained Earnings	(133.9 M)
	Working Capital	90.14 M
	Current Asset	8.77 M
	Current Liabilities	2.56 M
	Net Asset	312.16 M

About Harrow Health Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Harrow Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Harrow Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Harrow Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

TITAN	Titan Company Limited
U	Unity Software
PAYC	Paycom Soft

Additional Tools for Harrow Stock Analysis

When running Harrow Health's price analysis, check to measure Harrow Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harrow Health is operating at the current time. Most of Harrow Health's value examination focuses on studying past and present price action to predict the probability of Harrow Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Harrow Health's price. Additionally, you may evaluate how the addition of Harrow Health to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC